Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ O_*tDq,e
D$`$4mX@hP
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© w=~X 6[+3
Z/OERO
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© `U>]*D68
O81'i2MJ9
1.Co-stimulators (or co-stimulating molecules) zGP@!R`_
/K<>OyR?
2.NK-kB Y*S(uqM
m4R:K
jN*
3.Immunoglobulin superfamily
$;)A:*e
S AKIFNE
4.antigen-presenting cell (APC) TR:4$92:H
Bey9P)_O
f
5.death domain \{o<-S;h
E.CG
6.CCR and CXCR +,eF(VS!
"[CR5q9Pr
7.Lectin (or mitogen) W}WDj:
ZD4:'m`T/
8.Clusters of differentiation, CD) 9]g`VD6<v
=@d->d
9.B7 family kU{a!ca4
H9[0-Ur5
10.Cytotoxic T lymphocyte, CTL) 2xv[cpVi
gdg
"g6b
11.IL-15 and IL-15 receptor (IL-15R) \ns}
M3
<#)Q.P
12.MHC restriction Po\d!
)vGxF}I3
13.Affinity-chromatography ~8)l/I=`);
D*g
K, `
14.Cyctosprin A, CsA GFvLd:p` [
HgTBON(
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) {@[#
0gPH
e[db?f2!
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© }eSrJgF4M
~eXI}KhBw6
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 *1*i5c
/lc4oXG8
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ !HF<fn
&pHXSU
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 6h1pPx7zU
.qCI!%fg
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© i4)]lWnd
<=%G%V_s
ÃâÒßѧרҵ£º )qRE['M
L#N]1#;
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ /mK]O7O7
C-H6l6,
Ïû»¯ÄÚ¿Æ£º %Ybr5
$_
XLlJ|xhY-K
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ J>fq5
{&nDm$KTD
ѪҺ²¡Ñ§×¨Òµ£º }s.\B
u`pw'3hY
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿